Showing results (901-910 of 1,006) with videos related to

Sort By:
Pageof 101
Ejhaem|June 19, 2024
Long-term follow-up of outcomes including progression-free survival 2 in patients with transplant-ineligible multiple myeloma in the real-world practice: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) databaseRayan Kaedbey, Donna Reece, Christopher P Venner, et al.
Ejhaem|June 19, 2024
Case report: Sequential inotuzumab, blinatumomab, and chemotherapy with concurrent donor lymphocyte infusions induce complete remission in relapsed pre-B acute lymphoblastic leukemiaSina A Beer, Wolfgang Bethge, Christoph Faul, et al.
Ejhaem|June 19, 2024
Alpha globin gene alterations modifying the phenotype of homozygous beta thalassaemiaJyoti Shaw, Abhilipsa Patra, Anjumana Khatun, et al.
Ejhaem|April 18, 2024
Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry projectBriony Shaw, Eliza Chung, Cameron Wellard, et al.
Ejhaem|April 18, 2024
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusionShohei Mizuno, Akiyoshi Takami, Koji Kawamura, et al.
Ejhaem|April 18, 2024
Management of paroxysmal nocturnal hemoglobinuria in CALR mutated post-essential thrombocythemia myelofibrosis: A case reportMahija Cheekati, KarLeung Siu, Rachel Ochs
Ejhaem|April 18, 2024
A decade of chronic lymphocytic leukaemia therapy in Germany: Real-world treatment patterns and outcomes (2010-2022)Hannes Wartmann, Anna Kabilka, Barthold Deiters, et al.
Ejhaem|January 26, 2026
Successful Treatment of Refractory Sweet's Syndrome With Adalimumab in a Myelodysplastic Syndrome PatientLiya Ma, Yaojia Shen, Jie Chang, et al.
Ejhaem|February 2, 2026
Teclistamab in Elderly Patients With Relapsed/Refractory Multiple Myeloma: A Subgroup Analysis of the French RetrosTECtive CohortA Coste, S Godet, S Manier, et al.
Ejhaem|February 2, 2026
Venous Thromboembolism in Aggressive B-Cell Lymphoma Patients Treated with CD19 CAR-T Therapy: Single-Institution StudyNeha Venkatesh, Kevin Milligan, Julia Parrish, et al.
Pageof 101